To see the other types of publications on this topic, follow the link: Chronic bacterial prostatitis.

Journal articles on the topic 'Chronic bacterial prostatitis'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Chronic bacterial prostatitis.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Domingue, Gerald J., and Wayne J. G. Hellstrom. "Prostatitis." Clinical Microbiology Reviews 11, no. 4 (1998): 604–13. http://dx.doi.org/10.1128/cmr.11.4.604.

Full text
Abstract:
SUMMARY The laboratory diagnosis of acute bacterial prostatitis is straightforward and easily accomplished in clinical laboratories. Chronic bacterial prostatitis, and especially chronic idiopathic prostatitis (most often referred to as abacterial prostatitis), presents a real challenge to the clinician and clinical microbiologist. Clinically, the diagnosis of chronic idiopathic prostatitis is differentiated from that of acute prostatitis by a lack of prostatic inflammation and no “significant” (controversial) leukocytes or bacteria in the expressed prostatic secretions. Despite these diagnost
APA, Harvard, Vancouver, ISO, and other styles
2

Chandiok, S., P. G. Fisk, and V. C. Riley. "Prostatitis—Clinical and Bacterial Studies." International Journal of STD & AIDS 3, no. 3 (1992): 188–90. http://dx.doi.org/10.1177/095646249200300306.

Full text
Abstract:
Forty men with clinical prostatitis were studied to determine the value of symptomatology and categorization and 30 (75%) were classified as having prostatitis on the basis of prostatic localization studies. Of these 3 (10%) had chronic bacterial prostatitis, 18 (60%) had chronic abacterial prostatitis, and 9 (30%) had prostatodynia. No patient had acute bacterial prostatitis. Although Enterobacteriaciae were isolated from the 3 men with chronic bacterial prostatitis, these bacteria along with Staphlococcus aureus, Streptococcus faecalis, and Chlamydia trachomatis were isolated from a further
APA, Harvard, Vancouver, ISO, and other styles
3

Park, Heung Jae. "Chronic Bacterial Prostatitis." Korean Journal of Urogenital Tract Infection and Inflammation 9, no. 1 (2014): 21. http://dx.doi.org/10.14777/kjutii.2014.9.1.21.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Puerta Suárez, Jenniffer, and Walter D. Cardona Maya. "Microbiota, Prostatitis, and Fertility: Bacterial Diversity as a Possible Health Ally." Advances in Urology 2021 (September 28, 2021): 1–8. http://dx.doi.org/10.1155/2021/1007366.

Full text
Abstract:
Background. In health, microorganisms have been associated with the disease, although the current knowledge shows that the microbiota present in various anatomical sites is associated with multiple benefits. Objective. This study aimed to evaluate and compare the genitourinary microbiota of chronic prostatitis symptoms patients and fertile men. Materials and Methods. In this preliminary study, ten volunteers have included 5 volunteers with symptoms of chronic prostatitis (prostatitis group) and five fertile volunteers, asymptomatic for urogenital infections (control group) matched by age. Bact
APA, Harvard, Vancouver, ISO, and other styles
5

Bragina, E. E., L. G. Spivak, M. A. Gazimiev, and M. S. Evdokimov. "Effects of azoximer bovgialuronidase on bacterial biofilms in the ejaculate of patients with chronic prostatitis." Experimental and Сlinical Urology 16, no. 3 (2023): 87–92. http://dx.doi.org/10.29188/2222-8543-2023-16-3-87-92.

Full text
Abstract:
Introduction. The use of molecular biological methods in the analysis of bacterial diversity (metataxonomics) of prostate secretion and ejaculate to assess the male microbiota made it possible to identify the bacterial diversity of the microbiota in chronic prostatitis. At the same time, many strains of uropathogens identified in chronic prostatitis show the ability to form biofilms, while there are no generally accepted methods for treating infections caused by bacterial biofilms. Purpose of the study. To study the effect of bovhyaluronidase azoximer in chronic prostatitis, which may be due t
APA, Harvard, Vancouver, ISO, and other styles
6

Kanani, Suleman, Naheam Mujtaba, and Philip Sadler. "Acute and chronic prostatitis." InnovAiT: Education and inspiration for general practice 14, no. 1 (2020): 33–37. http://dx.doi.org/10.1177/1755738020966359.

Full text
Abstract:
Prostatitis is generally characterised as painful inflammation of the prostate, with or without bacterial infection. It is the most frequent urological diagnosis in men under 50 years in age, and the third most common urological diagnosis in men over that age. It tends to occur in young and middle-aged men. Prostatitis-like symptoms have a lifetime prevalence of up to 10%, although the proportion of these confirmed to be true prostatitis is unknown. The presentation of prostatitis can sometimes be vague and multifaceted. Initial therapy with antimicrobials remains the mainstay of treatment, al
APA, Harvard, Vancouver, ISO, and other styles
7

Colța, Artur. "CLINICAL MANIFESTATIONS AND SURGICAL TREATMENT MANAGEMENT OF BLADDER OUTLET OBSTRUCTION CAUSED BY THE CONSEQUENCES OF CHRONIC NON-BACTERIAL PROSTATITIS." Arta Medica 78, no. 1 (2021): 34–45. https://doi.org/10.5281/zenodo.4744430.

Full text
Abstract:
<strong>Objectives.</strong> The purpose of the scientific paper was to analyze data and evidence from existing sources for infravesical obstruction caused by the complications of nonbacterial chronic prostatitis. <strong>Materials and methods.</strong> Scientific publications were analyzed, which present evidence of infravesical obstruction caused by complications of chronic non-bacterial prostatitis and the role of endoscopic surgery in its treatment. As source of scientific literature, the following databases were used: Google Scholar, PubMed and eLibrary. The key words that were used in th
APA, Harvard, Vancouver, ISO, and other styles
8

Trishch, V. I., A. I. Mysak, and A. V. Trishch. "IMMUNE STATUS OF PATIENTS WITH CHRONIC PROSTATITIS." Ukrainian Journal of Urology, no. 1(5) (April 11, 2025): 89–94. https://doi.org/10.71217/uju.1(5).2025.89-94.

Full text
Abstract:
ANOTATION.The most common urological disease among men of working age is chronic prostatitis, and its symptoms are a frequent reason for seeking urological care. PURPOSE OF THE RESEARCH. Тo assess the state of local and systemic immunity in patients with various forms of chronic prostatitis MATERIALS AND METHODS. 84 patients with chronic prostatitis, with a long recurrent course of the disease, were under observation. Among them, there were 15 (17.9%) with chronic bacterial prostatitis, 69 (82.1%) with chronic bacterial prostatitis, of which 44 patients had chronic inflammatory pelvic pain syn
APA, Harvard, Vancouver, ISO, and other styles
9

Magri, V., E. Marras, and G. Perletti. "Chronic Bacterial Prostatitis: Enterococcal Disease?" Clinical Infectious Diseases 53, no. 12 (2011): 1306–7. http://dx.doi.org/10.1093/cid/cir709.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Magri, Vittorio, Matteo Boltri, Tommaso Cai, et al. "Multidisciplinary approach to prostatitis." Archivio Italiano di Urologia e Andrologia 90, no. 4 (2019): 227–48. http://dx.doi.org/10.4081/aiua.2018.4.227.

Full text
Abstract:
The modern clinical research on prostatitis started with the work of Stamey and coworkers who developed the basic principles we are still using. They established the segmented culture technique for localizing the infections in the males to the urethra, the bladder, or the prostate and to differentiate the main categories of prostatitis. Such categories with slight modifications are still used according to the NIH classification: acute bacterial prostatitis, chronic bacterial prostatitis, Chronic Pelvic Pain Syndrome (CPPS) and asymptomatic prostatitis. Prostatic inflammation is considered an i
APA, Harvard, Vancouver, ISO, and other styles
11

Almugbel, Saad Khalid, Fahad Khalaf Bakit Alanezi, Faisal Musaad Alhoshan, Rayan Osama Alkhalifa, Ali Hasan Alkhzaim, and Malik Abdulrahman Almohideb. "Classification and treatment of prostatitis: a review of literature." International Journal Of Community Medicine And Public Health 5, no. 11 (2018): 4941. http://dx.doi.org/10.18203/2394-6040.ijcmph20184247.

Full text
Abstract:
Prostatitis is one of the most common urinary tract diseases in men of all ages and is often challenging to manage. They can be classified based of the course of illness, presentation, and their etiology, and the investigation and treatment depend on how type of prostatitis. In this study we aim to look through the literature to find the various types of prostatitis and understand the respective methods of management. We did a systematic search for prostatitis using PubMed search engine (http://www.ncbi.nlm.nih.gov/) and Google Scholar search engine (https://scholar. google.com). The terms use
APA, Harvard, Vancouver, ISO, and other styles
12

Kutzler, Michelle. "Reproductive microbiome alterations: canine prostatitis." Clinical Theriogenology 11, no. 4 (2019): 649–58. http://dx.doi.org/10.58292/ct.v11.9467.

Full text
Abstract:
Prostate is the only accessory sex gland in dog. During periods of sexual rest, prostatic fluid is continuously and constitutively secreted into the proximal urethra where a small amount flows antegrade to exert bactericidal effects and to prevent ascent of lower urinary tract bacteria. Pathologic conditions of the prostate gland are common in dogs and their incidence increases with age. Bacterial prostatitis and benign prostatic hyperplasia account for ~ 85% of all prostatic disorders. Bacterial prostatitis can develop as an acutely fulminating emergency condition or as a chronic disorder in
APA, Harvard, Vancouver, ISO, and other styles
13

Phan, Van, Robert Belas, Brendan F. Gilmore, and Howard Ceri. "ZapA, a Virulence Factor in a Rat Model of Proteus mirabilis-Induced Acute and Chronic Prostatitis." Infection and Immunity 76, no. 11 (2008): 4859–64. http://dx.doi.org/10.1128/iai.00122-08.

Full text
Abstract:
ABSTRACT Our knowledge of pathogenesis has benefited from a better understanding of the roles of specific virulence factors in disease. To determine the role of the virulence factor ZapA, a 54-kDa metalloproteinase of Proteus mirabilis, in prostatitis, rats were infected with either wild-type (WT) P. mirabilis or its isogenic ZapA− mutant KW360. The WT produced both acute and chronic prostatitis showing the typical histological progressions that are the hallmarks of these diseases. Infection with the ZapA− mutant, however, resulted in reduced levels of acute prostatitis, as determined from low
APA, Harvard, Vancouver, ISO, and other styles
14

Tanner, Michael A., Daniel Shoskes, Asha Shahed, and Norman R. Pace. "Prevalence of Corynebacterial 16S rRNA Sequences in Patients with Bacterial and “Nonbacterial” Prostatitis." Journal of Clinical Microbiology 37, no. 6 (1999): 1863–70. http://dx.doi.org/10.1128/jcm.37.6.1863-1870.1999.

Full text
Abstract:
The etiology of chronic prostatitis syndromes in men is controversial, particularly when positive cultures for established uropathogens are lacking. Although identification of bacteria in prostatic fluid has relied on cultivation and microscopy, most microorganisms in the environment, including some human pathogens, are resistant to cultivation. We report here on an rRNA-based molecular phylogenetic approach to the identification of bacteria in prostate fluid from prostatitis patients. Positive bacterial signals were seen for 65% of patients with chronic prostatitis overall. Seven of 11 patien
APA, Harvard, Vancouver, ISO, and other styles
15

Cowan, Laine A., Jeanne A. Barsanti, Wayne Crowell, and John Brown. "Effects of castration on chronic bacterial prostatitis in dogs." Journal of the American Veterinary Medical Association 199, no. 3 (1991): 346–50. http://dx.doi.org/10.2460/javma.1991.199.03.346.

Full text
Abstract:
Summary An Escherichia coli bacterial prostatitis was experimentally induced in dogs to determine the effect of castration on chronic bacterial prostatitis. Two weeks after instillation of bacteria directly into the prostate gland, 17 of 22 adult mixed-breed male dogs had positive urine or prostatic fluid cultures or both. Seven of the 17 dogs were randomly chosen to be castrated, and 10 of the 17 served as sham-operated controls. At weekly intervals, urine was obtained from 17 dogs for aerobic microbiologic culturing. At each week, dogs with no bacterial growth in the cultured urine had prost
APA, Harvard, Vancouver, ISO, and other styles
16

Naumov, N. P., P. A. Scheplev, and S. К. Martazinova. "Rectal cream “Hem” (as suppositories) in treatment of chronic abacterial prostatitis." Andrology and Genital Surgery 22, no. 4 (2021): 97–102. http://dx.doi.org/10.17650/1726-9784-2021-22-4-97-102.

Full text
Abstract:
Chronic prostatitis is one of the most common disorders in men of reproductive age. In 5-10 % of cases, prostatitis is caused by bacterial infection. In 80-90 % of patients, bacterial agent cannot be detected, and chronic abacterial prostatitis is diagnosed per the National Institute of Health classification (NIH, 1995).Even with combination therapy using drugs of different groups, chronic prostatitis is a recurrent disorder and can lead to development of symptoms in the lower urinary tract and chronic pelvic pain syndrome decreasing patients' quality of life.Phytotherapy and beekeeping produc
APA, Harvard, Vancouver, ISO, and other styles
17

Zubkov, A. Yu, and N. A. Antonov. "Chronic bacterial prostatitis associated with androgen deficiency." Kazan medical journal 101, no. 3 (2020): 389–93. http://dx.doi.org/10.17816/kmj2020-389.

Full text
Abstract:
Inflammation of the prostate gland occupies a significant proportion of inflammatory diseases of the genitourinary system. According to J.Potts et al. (2007), prostatitis is detected in 510% of the general male population. Today, one of the main problems associated with prostatitis is the narrowly targeted, often unwarranted treatment with its antibacterial drugs without taking into account the multifactorial nature of the pathogenesis and androgen dependence of the prostate gland. As a result, this leads to ineffective treatment of prostatitis amid growing antibiotic resistance. In turn, rece
APA, Harvard, Vancouver, ISO, and other styles
18

Belyi, L. E. "Prospects of oral fosfomycin for the treatment of chronic bacterial prostatitis." Andrology and Genital Surgery 24, no. 3 (2023): 42–49. http://dx.doi.org/10.17650/2070-9781-2023-24-3-42-49.

Full text
Abstract:
The most frequent causative agent of chronic bacterial prostatitis is Escherichia coli, however, in recent years, the proportion of other gram-negative and gram-positive microorganisms in the structure of pathogens has been increasing. There is not only an increase in the proportion of extended-spectrum β-lactamases producing Escherichia coli, which ensures the resistance of bacteria to penicillins, cephalosporins and aztreonam, but also carbapenemases producing strains. The tendency of increasing resistance of uropathogens to fluoroquinolones is noted. An alternative for the treatment of bact
APA, Harvard, Vancouver, ISO, and other styles
19

Dumbraveanu, Ion, and Adrian Tanase. "Anti-inflammatory activity of Adenoprosin in nonbacterial prostatitis." Moldovan Medical Journal 60, no. 4 (2017): 3–9. https://doi.org/10.5281/zenodo.1105101.

Full text
Abstract:
<strong>Background: </strong>The treatment of chronic nonbacterial prostatitis remains an unexplained urology problem. Adenoprosin is a new entomological productcontaining lipoprotein extract of Lepidopteran insect species. Laboratory studies of the product have shown that it possesses antioxidant, antiproliferativeand anti-inflammatory properties. <strong>Material and methods: </strong>Nonbacterial prostatitis was experimentally modeled on 100 white Wistar rats. Adenoprosin, 150 mg rectal suppositories, wastested against the reference product Vitaprost, 50 mg rectal suppositories and placebo
APA, Harvard, Vancouver, ISO, and other styles
20

Islam, Md Shafiqul. "Prematur e Ejaculation and Chronic Bacterial Prostatitis." Medicine Today 29, no. 2 (2017): 21–25. http://dx.doi.org/10.3329/medtoday.v29i2.34621.

Full text
Abstract:
Premature ejaculation (PE) is regarded as the most common male sexual disorder. Previous studies reported that prostatic inflammation was highly prevalent in PE. However, the effect of antibiotic treatment of cases with PE and chronic prostatitis has not been extensively investigated. To examine the effect of antibiotic treatment in delaying ejaculation in patients with PE and chronic prostatitis. The study was carried out in my private chamber and at General Hospital N.Gong from June 2014 to December 2016. The study was performed with prior permission and the confidentiality was maintained. A
APA, Harvard, Vancouver, ISO, and other styles
21

Weidner, W., F. M. E. Wagenlehner, M. Marconi, A. Pilatz, K. H. P. Pantke, and T. Diemer. "Acute bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: andrological implications." Andrologia 40, no. 2 (2008): 105–12. http://dx.doi.org/10.1111/j.1439-0272.2007.00828.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Bratchikov, O. I., P. A. Dubonos, I. A. Tyuzikov, and E. A. Schumakova. "Mechanisms of oxidative stress in the pathogenesis of chronic bacterial prostatitis (literature review)." Andrology and Genital Surgery 23, no. 3 (2022): 19–28. http://dx.doi.org/10.17650/2070-9781-2022-23-3-19-28.

Full text
Abstract:
The review article, based on the results of modern clinical and experimental studies, discusses general issues of the pathophysiology of oxidative stress as a universal pathogenetic factor of human diseases and particular pathophysiological aspects of oxidative stress on the example of chronic bacterial prostatitis. Separately, the most studied mechanisms of oxidative stress in the pathogenesis of the infectious and inflammatory process associated with chronic bacterial prostatitis are highlighted, which contribute to the occurrence and persistence of oxidative disorders in the prostate gland
APA, Harvard, Vancouver, ISO, and other styles
23

Nickel, J. Curtis, and J. William Costerton. "Bacterial localization in antibiotic-refractory chronic bacterial prostatitis." Prostate 23, no. 2 (1993): 107–14. http://dx.doi.org/10.1002/pros.2990230204.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Tregunna, Rebecca. "Probiotics to treat chronic bacterial prostatitis." Nature Reviews Urology 18, no. 8 (2021): 444. http://dx.doi.org/10.1038/s41585-021-00502-z.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Baert, Luc, Andre Leonard, Marc D’Hoedt, and Rik Vandeursen. "Seminal Vesiculography in Chronic Bacterial Prostatitis." Journal of Urology 136, no. 4 (1986): 844–45. http://dx.doi.org/10.1016/s0022-5347(17)45099-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Pfau, A. "The treatment of chronic bacterial prostatitis." Infection 19, S3 (1991): S160—S164. http://dx.doi.org/10.1007/bf01643689.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Domingue, Gerald J. "Cryptic bacterial infection in chronic prostatitis." Current Opinion in Urology 8, no. 1 (1998): 45–49. http://dx.doi.org/10.1097/00042307-199801000-00009.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Neymark, Alexandr I., Andrei V. Davydov, and Irina V. Kablova. "Complex treatment of patients with chronic bacterial prostatitis using biologically active peptides." Urology reports (St. - Petersburg) 12, no. 3 (2022): 221–28. http://dx.doi.org/10.17816/uroved109913.

Full text
Abstract:
BACKGROUND: Increasing the effectiveness of the treatment of chronic bacterial prostatitis is an actual problem of modern urology.&#x0D; AIM: The aim of the study was to study the effectiveness of complex treatment of patients with chronic bacterial prostatitis using Prostatex.&#x0D; MATERIALS AND METHODS: This study included 94 patients with chronic bacterial prostatitis aged 21 to 45 years. Patients of group I (n = 47) received standard antibiotic therapy (levofloxacin at a dose of 500 mg 2 times a day for 28 days), and patients of group II (n = 47) received standard antibiotic therapy combi
APA, Harvard, Vancouver, ISO, and other styles
29

Kadyrov, Z. A., V. S. Stepanov, Sh V. Ramishvili, and Sh G. Mashaneishvili. "Diagnostics of chronic nonbacterial prostatitis." Andrology and Genital Surgery 20, no. 3 (2019): 36–42. http://dx.doi.org/10.17650/2070-9781-2019-20-3-36-42.

Full text
Abstract:
The connection between aseptic inflammation, infectious and autoimmune factors, oxidative stress in pathogenesis of chronic prostatitis, chronic pelvic pain syndrome and lower urinary tract symptoms is considered. The limitations of the currently accepted prostatitis classification and new principles to overcome them are discussed. The algorithms of prostatitis diagnosis offered by the Russian Society of Urologists and the European Association of Urology are described. Data on the current methods of detection of bacterial infection in prostatic fluid are presented.
APA, Harvard, Vancouver, ISO, and other styles
30

Nurimanov, Kamil, Olena Nedogonova, and Mariia Sherban. "Clinical and Laboratory Characteristics of Chronic Prostatitis / Chronic Pelvic Pain Syndrome." Health of Man, no. 1-2 (June 30, 2022): 42–48. http://dx.doi.org/10.30841/2307-5090.1-2.2022.263906.

Full text
Abstract:
Chronic prostatitis / chronic pelvic pain syndrome is a common urological disease that is the most common clinical form of chronic prostatitis. The combination in its pathogenesis of chronic inflammation of the prostate and chronic pain creates difficulties in diagnosis and treatment. This review aims to highlight modern approaches and diagnostic tools most commonly used in the practice of urology. The article presents the main clinical manifestations, modern classification and methods of research of patients with chronic prostatitis / chronic pelvic pain syndrome. Clinical and laboratory sign
APA, Harvard, Vancouver, ISO, and other styles
31

Nurimanov, Kamil, Olena Nedogonova, and Mariia Sherban. "Clinical and Laboratory Characteristics of Chronic Prostatitis/Chronic Pelvic Pain Syndrome." Health of Man, no. 1-2 (June 30, 2022): 42–48. https://doi.org/10.30841/2307-5090.1-2.2022.263906.

Full text
Abstract:
Chronic prostatitis / chronic pelvic pain syndrome is a common urological disease that is the most common clinical form of chronic prostatitis. The combination in its pathogenesis of chronic inflammation of the prostate and chronic pain creates difficulties in diagnosis and treatment. This review aims to highlight modern approaches and diagnostic tools most commonly used in the practice of urology. The article presents the main clinical manifestations, modern classification and methods of research of patients with chronic prostatitis / chronic pelvic pain syndrome. Clinical and laboratory sign
APA, Harvard, Vancouver, ISO, and other styles
32

Lia, Nadareishvili, Mchedlishvili Lasha, Nakaidze Nata, Dadiani Mariam, Nizharadze Dea, and Kutateladze Mzia. "Resolution of Chronic Bacterial Prostatitis with Bacteriophage-antibiotic Therapy." International Journal of Clinical Virology 8, no. 2 (2024): 026–30. http://dx.doi.org/10.29328/journal.ijcv.1001059.

Full text
Abstract:
Chronic bacterial prostatitis is a commonly diagnosed genitourinary infection that presents significant challenges both in diagnosis and treatment. In an upcoming era of antibiotic resistance, and limited therapeutic options it becomes imperative to revise current guidelines and to provide more effective treatment strategies. At the Eliava Phage Therapy Center (Tbilisi, Georgia) we utilize bacteriophage therapy as an alternative approach against chronic bacterial infections. Bacteriophages, viruses that target and lyse specific bacterial cells, can be used as a stand-alone treatment or in conj
APA, Harvard, Vancouver, ISO, and other styles
33

Ниткин, Д. М. "Immunomodulatory Therapy in the Complex Treatment of Chronic Bacterial Prostatitis." Репродуктивное здоровье. Восточная Европа 13, no. 4 (2023): 414–19. http://dx.doi.org/10.34883/pi.2023.13.4.012.

Full text
Abstract:
В последнее время в комплексном лечении хронического простатита актуальность приобретают методы иммунной модуляции и коррекции. В статье представлены результаты исследования эффективности применения иммуномодулятора Полиоксидоний (азоксимера бромида) в комплексной терапии хронического простатита. Азоксимера бромид в дозе 12 мг в форме ректальных свечей продемонстрировал иммунокорригирующий эффект, а также повысил клиническую и лабораторную эффективность лечения хронического бактериального простатита. Methods of immune modulation and correction have become relevant in the complex treatment of c
APA, Harvard, Vancouver, ISO, and other styles
34

Katibov, M. I., and M. M. Alibekov. "Modern approaches to the treatment of chronic bacterial prostatitis." Experimental and Сlinical Urology 15, no. 2 (2022): 130–39. http://dx.doi.org/10.29188/2222-8543-2022-15-2-130-139.

Full text
Abstract:
Introduction. The main treatment option for chronic bacterial prostatitis (CBP) is antimicrobial therapy. However, in connection with the steady increase in resistance to antimicrobial drugs and the high rate of failure in the treatment of such patients, it seems relevant to study new approaches to the treatment of this disease. Materials and methods. The review is based on articles published over the past 10 years (2011-2021) in scientific peer-reviewed journals included in the PubMed databases (https://www.ncbi.nlm.nih.gov/pubmed/) and the Scientific Electronic Library Elibrary.ru (https://e
APA, Harvard, Vancouver, ISO, and other styles
35

Anand, Anju, Elizabeth Tullis, Anne Stephenson, J. Curtis Nickel, and Michael J. Leveridge. "Pseudomonas aeruginosa bacteremia and prostatitis in a patient with cystic fibrosis." Canadian Urological Association Journal 7, no. 1-2 (2013): 1. http://dx.doi.org/10.5489/cuaj.173.

Full text
Abstract:
Patients with cystic fibrosis (CF) commonly suffer chronic respiratory infections, although systemic dissemination is relatively rare. Acute bacterial prostatitis presents dramatically and is believed to be mostly caused by local migration (with or without instrumentation) of the lower urinary tract and presents with a predictable microbial etiology. We report a case of a 26-year-old man presenting with acute Pseudomonas aeruginosa bacterial prostatitis due to hematogenous propagation from a chronic pulmonary infection.
APA, Harvard, Vancouver, ISO, and other styles
36

Marino, Andrea, Stefano Stracquadanio, Carlo Maria Bellanca, et al. "Oral Fosfomycin Formulation in Bacterial Prostatitis: New Role for an Old Molecule-Brief Literature Review and Clinical Considerations." Infectious Disease Reports 14, no. 4 (2022): 621–34. http://dx.doi.org/10.3390/idr14040067.

Full text
Abstract:
Bacterial prostatitis infections are described as infections that are difficult-to-treat, due to prostate anatomic characteristics along with clinical difficulty in terms of diagnosis and management. Furthermore, the emergence of multidrug resistant (MDR) bacteria, such as extended-spectrum beta-lactamase (ESBL) producer Escherichia coli, also representing the main causative pathogen in prostatitis, poses major problems in terms of antibiotic management and favorable clinical outcome. Oral fosfomycin, an antibiotic commonly used for the treatment of uncomplicated urinary tract infections (UTIs
APA, Harvard, Vancouver, ISO, and other styles
37

Ikeuchi, Takao, Nobuo Kawamura, Keizo Suzuki, and Shoichi Onodera. "Treatment of Chronic Bacterial Prostatitis with Tosufloxacin." Drugs 45, Supplement 3 (1993): 364–67. http://dx.doi.org/10.2165/00003495-199300453-00150.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Krupin, V. N., A. N. Belova, and A. V. Krupin. "Treatment of patients with chronic bacterial prostatitis." Herald Urology 7, no. 1 (2019): 26–37. http://dx.doi.org/10.21886/2308-6424-2019-7-1-26-37.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Ye, ZQ, RZ Lan, WM Yang, LF Yao, and X. Yu. "Tamsulosin Treatment of Chronic Non-bacterial Prostatitis." Journal of International Medical Research 36, no. 2 (2008): 244–52. http://dx.doi.org/10.1177/147323000803600205.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Langemeyer, T. N., W. H. Ferwerda, J. A. Hoogkamp-Korstantje, et al. "Treatment of Chronic Bacterial Prostatitis With Ciprofloxacin." Journal of Urology 141, no. 1 (1989): 222. http://dx.doi.org/10.1016/s0022-5347(17)40712-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Nickel, J. Curtis, and Timothy Moon. "Chronic bacterial prostatitis: An evolving clinical enigma." Urology 66, no. 1 (2005): 2–8. http://dx.doi.org/10.1016/j.urology.2004.12.028.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Weidner, W., and H. G. Schiefer. "Chronic bacterial prostatitis: Therapeutic experience with ciprofloxacin." Infection 19, S3 (1991): S165—S166. http://dx.doi.org/10.1007/bf01643690.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Cox, Clair E., and Stacy J. Childs. "Treatment of chronic bacterial prostatitis with temafloxacin." American Journal of Medicine 91, no. 6 (1991): S134—S139. http://dx.doi.org/10.1016/0002-9343(91)90326-s.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Ghobish, Ammar. "Voiding Dysfunction Associated with “Chronic Bacterial Prostatitis”." European Urology 42, no. 2 (2002): 159–62. http://dx.doi.org/10.1016/s0302-2838(02)00258-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Langemeyer, T. N. M., W. H. H. Ferwerda, J. A. A. Hoogkamp-Korstanje, et al. "Treatment of chronic bacterial prostatitis with ciprofloxacin." Pharmaceutisch Weekblad 9, S1 (1987): S78—S81. http://dx.doi.org/10.1007/bf02075268.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Mackenzie, Alexander R. "Estrogen treatment of a bacterial chronic prostatitis." Urology 27, no. 6 (1986): 574–75. http://dx.doi.org/10.1016/0090-4295(86)90352-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Заседа, Юрий. "ASSESSMENT OF THE EFFICIENCY OF THE APPLICATION OF THE COWBERRY AND BLUEBARRY PASTE IN COMPLEX TREATMENT OF CHRONIC BACTERIAL PROSTATITIS." Men’s Health, Gender and Psychosomatic Medicine, no. 1 (August 28, 2019): 7–12. http://dx.doi.org/10.37321/ujmh.2019.01-01.

Full text
Abstract:
In order to evaluate the eff ectiveness of cowberry and blueberry pastes in the complex treatment of chronic bacterial prostatitis, 72 patients of the Men’s Health clinic in Kyiv were examined. According to the survey results, 2 symmetric groups of 23 patients were formed. The main group was treated according to the model: antibiotic therapy, auxiliary pharmacotherapy (venotonic drugs and enzymes), local physiotherapy and diet therapy with the inclusion of cowberry and blueberry pastes. The control group received a similar treatment, but without changing the diet.Evaluating the eff ectiveness
APA, Harvard, Vancouver, ISO, and other styles
48

Ismailov, R. S., Y. L. Naboka, I. A. Gudima, K. S. Ibishev, and M. I. Kogan. "Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) 3a is a classic Chronic Bacterial Prostatitis (CBP)." European Urology 79 (June 2021): S185—S187. http://dx.doi.org/10.1016/s0302-2838(21)00520-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Gianneo, E., G. Conti, L. Fumagalli, and G. C. Comeri. "Transrectal lasertheraphy of chronic phlogosis." Urologia Journal 59, no. 1_suppl (1992): 36–40. http://dx.doi.org/10.1177/039156039205901s11.

Full text
Abstract:
Lasertherapy by means of high energy infrared laser generators at 904 nM with short and high frequency pulses (3,000 Hz and more) and mean power of 12 mW proved to be a good antiinflammatory and analgesic agent. 43 patients affected by prostatic inflammation underwent a cycle of transrectal lasertherapy and the authors evaluated the symptomatology, uroflowmetry and echographic pattern modifications. 5/8 patients affected by prostatic adenoma inflammation had a significant improvement from the subjective and clinical point of view; 3 patients with acute bacterial prostatitis had a complete reso
APA, Harvard, Vancouver, ISO, and other styles
50

Crocetto, Felice, Armando Calogero, Michele Santangelo, et al. "The Role of Butirprost® as an Adjuvant in Enhancing the Effect of Antibiotics in Patients Affected by Chronic Bacterial Prostatitis: A Randomized Prospective Trial." Medicina 61, no. 1 (2025): 148. https://doi.org/10.3390/medicina61010148.

Full text
Abstract:
Bacterial prostatitis (BP) is a common prostatic infection characterized by pain and urinary symptoms, often with negative bacterial cultures from prostatic secretions. It affects young and older men bimodally and impacts quality of life (QoL) significantly. Background and Objectives: Treatment typically involves antibiotics, but a multimodal approach with additional nutraceuticals may enhance outcomes. This study aimed to assess the efficacy of Butirprost® in association with fluoroquinolones in patients with chronic bacterial prostatitis (CBP). Materials and Methods: Patients diagnosed with
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!